United Therapeutics (UTHR) EV to EBITDA (2010 - 2026)
United Therapeutics' (UTHR) EV to EBITDA was 13.70 for Q2 2026, up 110.5% from 6.51 a year earlier but down 8.6% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) EV to EBITDA (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, United Therapeutics' EV to EBITDA came in at 8.45; for FY2025, it came in at 11.62, up 34.2% from FY2024.
- By year, EV to EBITDA came in at 8.66 in FY2024 (+45.9%), 5.94 in FY2023 (-38.6%), 9.66 in FY2022 (-25.1%) and 12.90 in FY2021 (+68.7%).
- Five-year quarterly EV to EBITDA spans a low of 5.68 in Q1 2024 and a high of 14.99 in Q1 2026.
- Year over year, EV to EBITDA has now increased in each of the last four quarters, with growth averaging 43.3% over the last eight quarters.
- The high point for year-over-year EV to EBITDA in five years was Q3 2021 (growth of 177.2%); the low point was Q1 2022 (a decline of 56.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 14.99 (Q1 2026), 11.62 (Q4 2025) and 9.66 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | United Therapeutics | 24.02 Bn | 13.52 Bn | 683.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.70 |
| Mar 31, 2026 | 14.99 |
| Dec 31, 2025 | 11.62 |
| Sep 30, 2025 | 9.66 |
| Jun 30, 2025 | 6.51 |
| Mar 31, 2025 | 7.14 |
| Dec 31, 2024 | 8.66 |
| Sep 30, 2024 | 9.41 |
| Jun 30, 2024 | 8.44 |
| Mar 31, 2024 | 5.68 |
| Dec 31, 2023 | 5.94 |
| Sep 30, 2023 | 6.71 |
| Jun 30, 2023 | 6.73 |
| Mar 31, 2023 | 7.39 |
| Dec 31, 2022 | 9.66 |
| Sep 30, 2022 | 6.76 |
| Jun 30, 2022 | 9.02 |
| Mar 31, 2022 | 6.11 |
| Dec 31, 2021 | 12.90 |
| Sep 30, 2021 | 12.57 |
API Access
United Therapeutics EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();